intellectual property

patent portfolio

Title

Use of Bucillamine in the Treatment of Infectious Diseases, including COVID-19

Title

62/991,996

Title

Provisional patent filed

Title

Title

Use of Bucillamine in the Treatment of Gout

Title

US9662305

Title

Granted – May 30, 2017

Title

Title

Use of Bucillamine in the Treatment of Neurological Brain Injury and Migraines

Title

63/546405

Title

Provisional patent filed

Title

Title

Method and use of Bucillamine in the Prevention and Treatment of Stroke

Title

PCT/CA2023/050425

Title

Non-Provisional patent filed

Title

Title

Bucillamine in the treatment of a victim exposed to a chemical warfare agent

Title

63/529230

Title

Provisional patent filed

Title

Title

Drug Delivery System

Title

  1. US 8642088
  2. US 9545423
  3. US 10104888

Title

  1. Issued on February 4, 2014
  2. Issued on January 17, 2017
  3. Issued on October 23, 2018

Title

Title

LONG COVID – Blood Biomarkers, Diagnosis and Treatment of Long-COVID

Title

PCT/CA2023/050145
PCT/CA2023/051292
No. 63/433,425

Title

Provisional patent filed

Title

Title

Methods for the Extraction and Crystallization of Psilocybin

Title

62/985,360

Title

Provisional patent filed

Title

Title

Psilocybin in the Treatment of Neurological Brain Injury

Title

63/011,493

Title

Provisional patent filed

Title

Title

Use of Psilocybin in the Treatment of Cancer

Title

63/133,913

Title

Provisional patent filed

Title

Title

Psilocybin Pharmaceutical Combination Therapies

Title

63/125,106

Title

Provisional patent filed

Title

Title

Use of Cannabidiol in the Treatment of Autoimmune Hepatitis

Title

US 8242178

Title

Issued on August 14, 2012

Title

USPTO No.

Status

Use of Bucillamine in the Treatment of Infectious Diseases, including COVID-19

62/991,996

Non-Provisional patent filed

Use of Bucillamine in the Treatment of Gout

US9662305

Granted – May 30, 2017

Use of Bucillamine in the Treatment of Neurological Brain Injury and Migraines

63/546405

Provisional patent filed

Method and use of Bucillamine in the Prevention and Treatment of Stroke

PCT/CA2023/050425

Non-Provisional patent filed

Bucillamine in the treatment of a victim exposed to a chemical warfare agent

63/529230

Provisional patent filed

Drug Delvery System

US 8642088
US 9545423
US 10104888
Issued on February 4, 2014
Issued On January 17, 2017
Issued On October 23, 2018

LONG COVID – Blood Biomarkers, Diagnosis and Treatment of Long-COVID

PCT/CA2023/050145
PCT/CA2023/051292
No. 63/433,425

Provisional patent filed

Methods for the Extraction and Crystallization of Psilocybin

62/985,360

Provisional patent filed

Psilocybin in the Treatment of Neurological Brain Injury

63/011,493

Provisional patent filed

Use of Psilocybin in the Treatment of Cancer

63/133,913

Provisional patent filed

Psilocybin Pharmaceutical Combination Therapies

63/125,106

Provisional patent filed

Use of Cannabidiol in the Treatment of Autoimmune Hepatitis

US 8242178
Issue on August 14, 2012